Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,895.20
(
0.09%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
94.07
(
-0.99%
)
Bitcoin
77,477.42
(
1.51%
)
News Focus
News Focus
Post# of 822354
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biosectinvestor

Send PM Follow Ignore
Followers 200
Posts 25596
Boards Moderated 0
Alias Born 04/03/2010

biosectinvestor

Re: HyGro post# 521592

Thursday, 10/13/2022 7:00:46 AM

Thursday, October 13, 2022 7:00:46 AM

Post# of 822354
That is a current trial, not the one that led to their approval. Note you did not give the Link. Those are the facts. Don’t deceive.

Those were not the primary endpoints for the trial that led to approval and the trial you took that from only started in July 2020.

It’s a combination trial with temozolomide.

https://clinicaltrials.gov/ct2/show/NCT04471844

Lies are no way to win an argument. It did not get approved based on OS but on PFS and a hypothetical OS, projected out 5 years. The current trial you referred to has not even run 5 years yet. I will be interested to see how that one turns out, but your post misleads in response to mine.

I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News